LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Replicate Assay Well Timepoint Timepoint Unit Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value
BT-20 XMD16-144
1.11
uM
LJP5
 1
M09
 72
hr
 1334 1156 3930 0.2941 -0.0881
BT-20 XMD16-144
1.11
uM
LJP5
 2
M09
 72
hr
 1334 1138 4051 0.2809 -0.0947
BT-20 XMD16-144
1.11
uM
LJP5
 3
M09
 72
hr
 1334 1183 4117 0.2873 -0.0715
BT-20 XMD16-144
3.33
uM
LJP5
 1
M08
 72
hr
 1334 1228 3930 0.3124 -0.0521
BT-20 XMD16-144
3.33
uM
LJP5
 2
M08
 72
hr
 1334 1253 4051 0.3093 -0.0387
BT-20 XMD16-144
3.33
uM
LJP5
 3
M08
 72
hr
 1334 1162 4117 0.2822 -0.0817
BT-20 XMD16-144
10
uM
LJP5
 1
M07
 72
hr
 1334 808 3930 0.2056 -0.2754
BT-20 XMD16-144
10
uM
LJP5
 2
M07
 72
hr
 1334 834 4051 0.2059 -0.2544
BT-20 XMD16-144
10
uM
LJP5
 3
M07
 72
hr
 1334 814 4117 0.1977 -0.2623
BT-20 Erlotinib
0.04
uM
LJP5
 1
M24
 72
hr
 1334 3675 3930 0.9349 0.9155
BT-20 Erlotinib
0.04
uM
LJP5
 2
M24
 72
hr
 1334 3481 4051 0.8593 0.8193
BT-20 Erlotinib
0.04
uM
LJP5
 3
M24
 72
hr
 1334 3883 4117 0.9430 0.9291
BT-20 Erlotinib
0.12
uM
LJP5
 1
M23
 72
hr
 1334 3798 3930 0.9662 0.9564
BT-20 Erlotinib
0.12
uM
LJP5
 2
M23
 72
hr
 1334 3763 4051 0.9289 0.9100
BT-20 Erlotinib
0.12
uM
LJP5
 3
M23
 72
hr
 1334 3852 4117 0.9355 0.9196
BT-20 Erlotinib
0.37
uM
LJP5
 1
M22
 72
hr
 1334 3781 3930 0.9619 0.9508
BT-20 Erlotinib
0.37
uM
LJP5
 2
M22
 72
hr
 1334 3995 4051 0.9862 0.9827
BT-20 Erlotinib
0.37
uM
LJP5
 3
M22
 72
hr
 1334 4108 4117 0.9977 0.9971
BT-20 Erlotinib
1.11
uM
LJP5
 1
M21
 72
hr
 1334 3505 3930 0.8917 0.8581
BT-20 Erlotinib
1.11
uM
LJP5
 2
M21
 72
hr
 1334 3616 4051 0.8926 0.8631
BT-20 Erlotinib
1.11
uM
LJP5
 3
M21
 72
hr
 1334 3541 4117 0.8600 0.8227
BT-20 Erlotinib
3.33
uM
LJP5
 1
M20
 72
hr
 1334 3597 3930 0.9151 0.8893
BT-20 Erlotinib
3.33
uM
LJP5
 2
M20
 72
hr
 1334 3876 4051 0.9568 0.9456
BT-20 Erlotinib
3.33
uM
LJP5
 3
M20
 72
hr
 1334 3786 4117 0.9195 0.8993
BT-20 Erlotinib
10
uM
LJP5
 1
M19
 72
hr
 1334 2646 3930 0.6732 0.5514